US approves sickle cell breakthrough with gene editing therapy
The United States has approved breakthrough gene editing therapy using the CRISPR tool to treat sickle cell disease. This is a major advancement in gene therapy for patients with sickle…
£1.9 million funding supports research on drivers of health disparities and infection risk across England
Dr Rosalind Eggo, an Associate Professor at LSHTM, has been awarded over £1.9 million in funding to research health disparities and associated infectious disease burden across England. Health disparities are…
Are No-Spray Christmas Trees Better for You? What to Know
The article discusses the benefits and popularity of no-spray, pesticide-free Christmas trees among environmentally concerned customers. It highlights the success of Reed Island Christmas Tree Farm in southern Virginia, which…
FDA OKs Two Gene-Editing Therapies for Sickle Cell Disease
The FDA approved two gene-editing treatments for patients aged 12 years or older with severe sickle cell disease, marking the first cell-based gene therapies for the condition. Exa-cel uses CRISPR…
Flaxseeds For Breast Cancer? Study Says Manipulating Gut Microbiota Using Them Could Reduce Risk
Researchers conducted a study on the manipulation of gut microbiota using flaxseeds and found that it could be beneficial in the prevention of breast cancer. Flaxseed is known for various…